Awardee OrganizationWOMEN AND INFANTS HOSPITAL-RHODE ISLAND
Description
Abstract Text
DESCRIPTION: (Provided By Applicant) Vitamin A (retinol) supplied by the mother
to her fetus is essential for normal embryogenesis, fetal development, and
neonatal survival. The major source of vitamin A in mammals is oxidative
cleavage of the principal dietary provitamin A carotenoid, beta-carotene (betaC).
Epidemiologic and animal investigations indicate betaC and other carotenoids
have pregnancy-promoting actions. An intriguing finding is that several of
these properties apparently are independent of provitamin A activity. In
Preliminary Studies, we have shown that placental trophoblast metabolizes betaC
to retinol via the principal betaC cleavage enzyme, betaC-15,15'-dioxygenase
(betaCDO). In addition, we have shown specific provitamin A and non-pro vitamin
A carotenoids modulate placental growth and differentiation by actions on
trophoblast gene expression. These observations have prompted the following
experimental questions: (a) Does placental regulation of BetaC to retinoid
metabolism serve a physiologic role akin to the placental enzymatic barrier
functions which maintain intrauterine glucocorticoid and vitamin D
homeostasis?; and (b) Do specific dietary carotenoids promote normal pregnancy
by a combination of genomic and nongenomic events in uteroplacental target
cells? This proposal addresses deficiencies of current understanding about
nutritional regulation of intrauterine physiology. In order to characterize the
cellular changes induced by carotenoids and to determine relevant molecular
mechanisms, we will combine: well-characterized trophoblast cell culture
models, systems for uniform delivery of bioavailable carotenoids over a wide
concentration range, and biochemical and molecular biological analysis of
carotenoid metabolism in intact cells and placental tissue. We will test the
hypotheses: (a) Placental betaC-1 5,1 5'-dioxygenase (betaCDO) activity is the
major (or sole) enzymatic route for fetal biotransformation to retinal, the
precursor of retinoic acids. (b) Nutrient and hormonal regulation of placental
betaCDO gene expression and enzyme activity modulate fetal exposure to
potentially deleterious fluctuations of maternal vitamin A. We also will
determine which specific carotenoids are important gestational age-dependent
regulators of placental gene expression and trophoblast proliferation,
migration/invasiveness and survival. Finally, we will establish whether these
biological activities require carotenoid conversion to retinoids or carotenoid
antioxidant activities. These studies will provide new information about
potentially critical aspects of intrauterine homeostasis. Consequently, this
research will increase understanding and suggest interventional strategies for
vitamin A deficiency in pregnancy, a major global public health problem.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
069851913
UEI
VUYJL5Q7YCZ3
Project Start Date
27-June-2002
Project End Date
30-June-2005
Budget Start Date
01-June-2005
Budget End Date
30-June-2005
Project Funding Information for 2005
Total Funding
$6,957
Direct Costs
$4,994
Indirect Costs
$1,963
Year
Funding IC
FY Total Cost by IC
2005
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$6,957
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD042174-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD042174-04
Patents
No Patents information available for 5R01HD042174-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD042174-04
Clinical Studies
No Clinical Studies information available for 5R01HD042174-04
News and More
Related News Releases
No news release information available for 5R01HD042174-04
History
No Historical information available for 5R01HD042174-04
Similar Projects
No Similar Projects information available for 5R01HD042174-04